Transvaginal Mesh Lawsuit Filed by Gilman Law LLP on Behalf of Nebraska Woman Allegedly Injured by Boston Scientific Pelvic Mesh
Boston Scientific Transvaginal Mesh Lawsuit Filed by Gilman Law LLP Joins More Than 5,300 Similar Claims Pending Against the Company in Federal Court.
Boston, MA (PRWEB) August 08, 2013
Gilman Law LLP, a leading pharmacy law and defective medical device plaintiffs’ law firm, announces it has filed a transvaginal mesh lawsuit on behalf of a Nebraska woman who was allegedly injured by a Boston Scientific pelvic mesh device. According to court documents, the complaint, which was filed on July 31, 2013, joins more than 5,300 similar transvaginal mesh lawsuits pending against Boston Scientific Corp. in a multidistrict litigation underway in U.S. District Court, Southern District of West Virginia. (Case No. Case 2:13-cv-11111)
The defective medical device law firm of Gilman Law LLP can provide a free legal consultation with no cost or obligation to women who may have suffered severe complications allegedly due to transvaginal mesh products manufactured by Boston Scientific, including:
- Mesh erosion through the vaginal tissue, may cause the skin to split
- Mesh extrusion and exposure.
- Perforation or puncture of bladder, intestines, bowels, and/or vaginal wall
- Protrusion or lump in the vaginal opening
- Recurrence of pelvic organ prolapse
- Recurrence of stress urinary incontinence
- Urinary problems
- Vaginal bleeding, pain and discomfort, chronic drainage, discharge, infections, scarring and/or shrinkage
- Painful sexual intercourse
Women considering filing a transvaginal mesh lawsuit should be aware that all personal injury claims are subject to a strict statute of limitations that varies by state. To ensure that their right to recovery is not put in jeopardy, alleged victims of transvaginal mesh are urged to contact our transvaginal mesh lawyers today, TOLL FREE at 888-252-0048 or submit a free legal consultation form online.
The plaintiff being represented by Gilman Law LLP’s transvaginal mesh lawyers was implanted with a Boston Scientific Kit in May 2010. According to court documents filed in the Southern District of West Virginia, Boston Scientific Corp. manufacturers a number of transvaginal mesh products used to treat pelvic organ prolapse and stress urinary incontinence, including:
- The Uphold Vaginal Support System
- The Pinnacle Pelvic Floor Repair Kit
- The Advantage Transvaginal Mid-Urethral Sling System
- The Advantage Fit System
- The Lynx Suprapubic Mid-Urethral Sling System
- The Obtryx Transobturator Mid-Urethral Sling System
- The Prefyx PPS System
- The Solyx SIS System
The Food & Drug Administration (FDA) issued its first communication regarding the dangers associated with transvaginal mesh in October 2008, and followed up with a second public warning in July 2011. According to the FDA, transvaginal mesh complications following pelvic organ prolapse repair are not rare. What’s more, the agency also stated that it is “not clear that transvaginal POP repair with mesh is any more effective than traditional [transvaginal surgery without mesh] … and may expose patients to greater risk.”
http://www.fda.gov/downloads/MedicalDevices/Safety/AlertsandNotices/UCM262760.pdf; FDA, July 2011
Gilman Law LLP is providing complimentary lawsuit consultations to women who suffered severe complications, including tremendous pain and suffering, following implantation of transvaginal mesh. For more information, please contact Gilman Law LLP today by visiting our website to fill out a free, no obligation case evaluation form, or call Toll Free at 1-888-252-0048.
About Gilman Law LLP
Gilman Law LLP, a leading pharmaceutical law and defective drug law firm, has been recognized for delivering successful results to their clients across a broad range of claims stemming from consumer product injury, mass tort, and class action lawsuits. For over 33 years, the Gilman Law LLP team of highly experienced lawyers has earned renown for tireless work on behalf of their clients on many of today’s most challenging and important legal issues.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/8/prweb11002365.htm